Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers discover treatment for spinal cord injury pain

28.11.2006
Spinal cord injury patients with moderate to severe nerve pain experienced less pain and in some cases no pain while taking the drug pregabalin, according to a study published in the November 28, 2006, issue of Neurology, the scientific journal of the American Academy of Neurology.

"The findings are promising as spinal cord injury pain is a condition which generally responds poorly to currently available treatments," said study author Philip J. Siddall, MBBS, PhD, with Royal North Shore Hospital in Sydney, Australia.

The study, considered to be the largest randomized controlled trial of spinal cord injury patients with nerve pain, involved 137 adults in Australia over a 12-week period. Half of the group received pregabalin; the other half received a placebo.

Researchers found at the end of 12 weeks, fewer than 16 percent of patients taking pregabalin had severe pain compared with 43 percent in the placebo group. And over one-third of patients in the pregabalin group had no or mild pain.

The study also found pregabalin reduced sleep and anxiety problems compared to the placebo group.

"Pregabalin was significantly more effective in relieving pain, improving sleep, anxiety, and overall well-being in patients with spinal cord injury compared to placebo," said Siddall. "Fifty-seven percent of patients taking pregabalin said they felt better overall compared to 21 percent in the placebo group."

Siddall said the pain relief was rapid as the pregabalin group had significant pain relief after the first week of the study. The drug's most common side effects were dizziness and drowsiness.

Nerve pain is estimated to occur in up to 40 percent of people with spinal cord injury. According to the National Spinal Cord Injury Association, as many as 450,000 people in the United States have spinal cord injuries and about 11,000 people sustain new spinal cord injuries each year.

Angela Babb | EurekAlert!
Further information:
http://www.aan.com

More articles from Health and Medicine:

nachricht A promising target for kidney fibrosis
21.04.2017 | Brigham and Women's Hospital

nachricht Stem cell transplants: activating signal paths may protect from graft-versus-host disease
20.04.2017 | Technische Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

DGIST develops 20 times faster biosensor

24.04.2017 | Physics and Astronomy

Nanoimprinted hyperlens array: Paving the way for practical super-resolution imaging

24.04.2017 | Materials Sciences

Atomic-level motion may drive bacteria's ability to evade immune system defenses

24.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>